Dr. Leventhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 North St Clair Street
Suite 1900
Chicago, IL 60611Phone+1 312-695-9019
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Abdominal Transplant Surgery, 1996 - 1998
- University of MinnesotaResidency, Surgery, 1987 - 1996
- State University of New York Downstate Medical Center College of MedicineClass of 1987
Certifications & Licensure
- IL State Medical License 1996 - 2026
- IN State Medical License 2008 - 2017
- MN State Medical License 1990 - 1996
- American Board of Surgery Surgery
Clinical Trials
- Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion Start of enrollment: 2008 Mar 01
- TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation Start of enrollment: 2020 Feb 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 57 citationsRenal transplant function after ten years of cyclosporineP. S. Almond, K. J. Gillingham, Richard K. Sibley, A. Moss, M. Melin
Transplantation. 1992-02-01 - 113 citationsResolution of recurrent focal segmental glomerulosclerosis after retransplantation.Lorenzo Gallon, Joseph R. Leventhal, Anton I. Skaro, Yashpal S. Kanwar, Antonio Alvarado
The New England Journal of Medicine. 2012-04-25 - 31 citationsAntibody Removal by Column Immunoabsorption Prevents Tissue Injury in an Ex Vivo Model of Pig-to-Human Xenograft Hyperacute RejectionTimothy J. Kroshus, Agustin P. Dalmasso, Joseph R. Leventhal, Ranjit John, Arthur J. Matas
The Journal of Surgical Research. 1995-07-01
Press Mentions
- Stem Cells Instead of Drugs? Northwestern Trial Testing a Way to Help Strengthen Transplant Patients’ Immune SystemsDecember 29th, 2021
- Talaris Therapeutics Presents High-Resolution Analysis of HLA Mismatching in Phase 2 Trial in Living Donor Kidney TransplantDecember 14th, 2021
- Severe COVID-19 Negatively Impacts Kidney Function in Kidney Transplant RecipientsAugust 31st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: